Titan Medical begins process to move to the TSX Venture Exchange
TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that its board of directors (the “Board”) has approved the voluntary delisting (the “Delisting”) of Titan’s common shares (the “Titan Shares”) from the Toronto Stock Exchange (the “TSX”). Subject to approval by the TSX and the completion of all closing conditions for the Transaction (defined below) it is expected that the Titan Shares will be delisted from the TSX effective as of close of markets between October 4, 2024 and October 10, 2024.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same.